Datar Cancer Genetics Limited
Atreyee Saha, PhD, is an accomplished professional in the field of medical genetics and oncology, currently serving as the Director of Laboratory and Technologies at Datar Cancer Genetics Limited since December 2022. With extensive experience in both technical operations and commercial management, Atreyee oversees the IVD Medical Laboratory and champions a broad portfolio of multi-cancer management tests. Previous roles include Senior General Manager at Datar Cancer Genetics, where Atreyee established collaborations with prestigious NHS organizations and led funding initiatives, and Head of Integration at LEX Diagnostics, leading a multidisciplinary team in developing a point-of-care qPCR device. At DNA Electronics, Atreyee held several key positions, including New Applications Manager, where leadership in the development of rapid NGS medical devices for oncology was demonstrated. At Vela Diagnostics, Atreyee successfully launched CE-IVD products and at Life Technologies, Atreyee initiated a Next Generation Sequencing core facility. Atreyee holds a PhD in Human/Medical Genetics from the Indian Institute of Chemical Biology and is also a certified life coach.
This person is not in any teams
This person is not in any offices
Datar Cancer Genetics Limited
We are a World-leading molecular oncology facility with a fully equipped laboratory, integrated process platforms, in-house bioinformatics team, and a huge genetic data base for precise and updated reporting. The facility is NABL, ISO, CAP and CLIA accredited. National and international cancer research institutes, and patients from all over the world including US, Switzerland, Germany and UK avail our services. With the help of latest technology and several years of extensive research, we offer highly effective treatment solutions to cancer patients for whom, multiple lines of treatment have failed. Our state-of-the-art cancer research centre is spread over 40,000 sq.ft. with a formidable team of cancer researchers, doctors, scientists and other technologists educated and trained at top universities and institutes around the world. Our entire team is always at the disposal of clinicians and cancer patients to bring cutting-edge treatment options in the most challenging cases.